Full Service CRO
Since 1992, we have completed over 400 studies successfully and continue to serve clients globally. CMX focuses on clinical excellence from Proof of Concept Trials through to the delivery of pre-marketing and pivotal trials to post-registration support.
Some of our Current Studies
A Single, Blind, Two-Stage Dose-Finding Study to Evaluate the Safety, Tolerability and Efficacy of a Single Liproca® Depot Injection into the Prostate in Patients with Localized Prostate Cancer, Assigned to Active Surveillance who are at High Risk for Disease Progression (followed by an Open Label Extension with a Repeat Injection (Optional))
Androgen Deprivation with Goserelin Acetate (Zoladex®): An Assessment of The Standard of Care in Early and Late Stage Prostate Cancer in Canada. A Real World Observational Registry (ZOLAPT)
A Prospective, Single Arm Study in Prostate Cancer Patients Managed with Androgen Deprivation Therapy to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training (ELIFIT)
A Canadian Observational Study in Metastatic Cancer of the Prostate: A study of Zytiga Use in the Community Urology Setting. The COSMIC Prospective Prostate Cancer Study
A 150-Day, Prospective, Phase IV, Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement when Treating Male Hypogonadism with Testosterone Nasal Gel (Natesto™) My-T Study
Validation Study: A Prospective, Non-Randomized, Single Arm Trial To Assess The Efficacy Of The Comfort Plug™ In Preventing Urinary Incontinence In Male Subjects With Sphincteric Incompetence (COMFORT STUDY)
Parallel Group Single Blind Study to Compare the Pharmacokinetic Profiles and Pharmacodynamic Response of a drug XXXX in Ambulatory Patients with Advanced Carcinoma of the Prostate
Canadian Real Life Evaluation of the Effect of Diet and Exercise in Prostate Cancer Patients Managed with Lupon: (CRONOS II)
And many more...
Let CMX Research Inc. plan and implement your Clinical Development Programs. Please fill in the form below or call us at 1-877-290-0018.